About Ipsum
Ipsum is a company based in Medellin (Colombia) founded in 2014. It operates as a Professional Services. Ipsum has raised $200 thousand across 1 funding round from investors including GITP Ventures. Ipsum offers products and services including Site Management Services, Clinical Research Services, and Technology Services. Ipsum operates in a competitive market with competitors including United BioSource Corporation, Launch Therapeutics, Xgene Pharmaceutical, Hikinger Pharmaceutical Technology and Concentrics Research, among others.
- Headquarter Medellin, Colombia
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$200 K (USD)
in 1 rounds
-
Latest Funding Round
$200 K (USD), Seed
Jul 02, 2015
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Ipsum
Ipsum offers a comprehensive portfolio of products and services, including Site Management Services, Clinical Research Services, and Technology Services.
Patients are recruited and retained for efficient trial management.
Clinical research documents are designed per international standards.
Software solutions are provided for medical device companies.
Funding Insights of Ipsum
Ipsum has successfully raised a total of $200K through 1 strategic funding round. The most recent funding activity was a Seed round of $200 thousand completed in July 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Ipsum
Ipsum has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include GITP Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked |
Investor details for Ipsum
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Ipsum
Investment portfolio details for Ipsum
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Ipsum
Detailed financials for Ipsum
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ipsum Comparisons
Peer comparison for Ipsum
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Ipsum
Ipsum operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as United BioSource Corporation, Launch Therapeutics, Xgene Pharmaceutical, Hikinger Pharmaceutical Technology and Concentrics Research, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical support services
|
|
| Locked | Locked | Locked |
Late-stage clinical development services are provided for biopharma companies.
|
|
| Locked | Locked | Locked |
Developer of pharmaceutical products for treating neurological diseases and chronic pain
|
|
| Locked | Locked | Locked |
Phase I-IV drug research and development services are provided.
|
|
| Locked | Locked | Locked |
Late-stage (Phase II-IV trials) CRO
|
Detailed competitors of Ipsum
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ipsum
Complete news archive for Ipsum
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ipsum
Ipsum was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Ipsum is headquartered in Medellin, Colombia. It is registered at Medellin, Antioquia, Colombia.
Ipsum is a funded company, having raised a total of $200K across 1 funding round to date.
Ipsum is established as a prominent site management organization specializing in clinical trials with a focus on local expertise. Services are provided to biopharmaceutical companies to enhance their success probability through patient recruitment, trial preparation, management, and retention. Solutions are offered across various therapeutic areas including tropical diseases, cardiovascular, medical devices, and metabolic disorders. Trials are conducted at fewer sites with increased efficiency, ensuring consistent quality across the country. Collaboration with clients is emphasized to navigate the complex healthcare environment and bring innovative products to market.
Ipsum's top competitors include United BioSource Corporation, Xgene Pharmaceutical and Concentrics Research.
Ipsum offers Site Management Services, Clinical Research Services, and Technology Services.
Ipsum has 1 investor. Key investors include GITP Ventures.